PepGen Inc. (PEPG) stock
PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.04−0.22 (-4.18%)
Close on Nov 12, 2026Market cap $349.07MP/E –Yield –
PepGen ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
PepGen's ebitda for the twelve months ending Sep 30, 2026 was -$76.87M. For fiscal 2025 it was -$92.21M. The highest annual figure on record is -$26.91M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$92.21M | – |
| FY2024 | Dec 31, 2024 | -$96.24M | – |
| FY2023 | Dec 31, 2023 | -$83.57M | – |
| FY2022 | Dec 31, 2022 | -$67.80M | – |
| FY2021 | Dec 31, 2021 | -$26.91M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$20.18M | – |
| Q2 FY2026 | Jun 30, 2026 | -$18.64M | – |
| Q1 FY2026 | Mar 31, 2026 | -$18.64M | – |
| Q4 FY2025 | Dec 31, 2025 | -$19.41M | – |
| Q3 FY2025 | Sep 30, 2025 | -$18.35M | – |
| Q2 FY2025 | Jun 30, 2025 | -$23.63M | – |
| Q1 FY2025 | Mar 31, 2025 | -$30.92M | – |
| Q4 FY2024 | Dec 31, 2024 | -$23.95M | – |
| Q3 FY2024 | Sep 30, 2024 | -$22.77M | – |
| Q2 FY2024 | Jun 30, 2024 | -$30.03M | – |
| Q1 FY2024 | Mar 31, 2024 | -$19.40M | – |
| Q4 FY2023 | Dec 31, 2023 | -$20.41M | – |
| Q3 FY2023 | Sep 30, 2023 | -$24.48M | – |
| Q2 FY2023 | Jun 30, 2023 | -$20.84M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.83M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.01M | – |
| Q3 FY2022 | Sep 30, 2022 | -$19.45M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.54M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.79M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.11M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.98M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.09M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.58M | – |
See a number that looks wrong?